Psilocybin Blocks Chemotherapy-Induced Nerve Pain in Mice

Researchers at the University of Texas MD Anderson Cancer Center have discovered that psilocybin, the psychoactive compound found in magic mushrooms, can prevent the development of chronic nerve pain in mice subjected to chemotherapy. This finding offers a potential breakthrough for cancer patients who often suffer from debilitating peripheral neuropathy, a condition characterized by nerve damage in the extremities that can persist for years after treatment. The study, published this week in the journal Nature, involved administering two doses of psilocybin to mice before they began a six-month course of six chemotherapy rounds. In contrast, a control group of mice that did not receive psilocybin developed hypersensitivity to pain, reduced sensation in their paws, and damage to sensory nerve fibers in their skin. The mice treated with psilocybin, however, completed the chemotherapy without any observable nerve damage or sensory deficits. Crucially, the chemotherapy remained effective in reducing tumors for both the psilocybin-treated group and the control group, indicating that psilocybin did not interfere with the cancer-fighting efficacy of the treatment. Scientists hypothesize that psilocybin may protect nerve cells by maintaining the normal function and movement of mitochondria, the energy-producing components within cells, along their designated pathways. Dr. Moran Amit, co-leader of the research group, emphasized the critical need for treatments that can prevent nerve injury without compromising the effectiveness of life-saving chemotherapy. The promising results from this preclinical study have paved the way for human trials, which are scheduled to commence this month. Peripheral neuropathy, the condition investigated, affects a significant number of cancer patients undergoing chemotherapy, leading to long-term pain and reduced quality of life. Current treatments for this type of nerve pain are often limited in their effectiveness and can have their own side effects. The potential for psilocybin to offer a preventative solution, rather than just a treatment for existing pain, marks a significant advancement in supportive cancer care research. The research team's focus on the mechanism of action, specifically the role of mitochondria, provides a scientific basis for further investigation and development of psilocybin-based therapies for chemotherapy-induced nerve damage. This study represents a significant step in exploring the therapeutic applications of psychedelics beyond their known mental health benefits, extending into the realm of physical symptom management in serious medical conditions.